Ireland
--:--IST
Recruiting Not applicable

The Effect of a Music Intervention on Postictal Agitation in Electroconvulsive Therapy Patients

NCT06817330 · tracked via the Priya Life Science Netherlands tracker
Phase
Not applicable
Started
2025-11-25
Last updated
2025-12-17

Condition(s) studied

Music InterventionElectroconvulsive Therapy Treated PatientsAgitation on Recovery From Sedation

Investigational drug(s) / intervention(s)

Intervention group, listening to recorded musicControl group, headphones with no music

Intervention group, listening to recorded music: Participants in the group receiving music will be offered a tablet with several pre-created playlists. When the patient has made a selection, they will listen to music via headphones for 30 minutes before each ECT treatment session. The headphones will be removed and the music stopped after the 30 minutes. After active ECT treatment, the headphones will be put back on the patient and the music played for another 12 minutes while the patient is recovering and moved to the recovery room. If patients protest against the music and/or headphones, the researcher will ask them to put the headphones back on. If the patient still protests after asking to put the headphones back on, this will be written down by the researcher, with the amount of time without the (control) intervention noted. No coercion will be used during the whole study process.

Control group, headphones with no music: The control group will wear headphones without music for the same duration as the music group (30 minutes before ECT and 12 minutes after ECT) to reduce bias and achieve a similar level of background-noise dampening.

Study summary

This study will investigate the effect of music on postictal agitation when played peri-interventionally for patients undergoing electroconvulsive therapy for severe depression.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients undergoing ECT treatment for depression (including depression as part of bipolar disorder) * Adult patients (≥18 years) * Hypnotic agent used is etomidate * Sufficient understanding of the Dutch language (in judgement of the attending physician or researcher) * Written informed consent by patient or legal representative Exclusion Criteria: * Significant impaired hearing (defined as unable to communicate verbally or listen to music) * Severe neurological condition (defined as interfering with the ability to process music) * Patients receiving ECT for treatment of schizophrenic disorders

Primary outcome measure(s)

  • Presence or absence of postictal agitation — First 30 minutes post-ECT session
    The primary outcome measure is the presence or absence of postictal agitation (PIA). All patients will be screened for PIA using the RASS (Richmond Agitation-Sedation Scale), a 10-point scale, indicating alertness and responsiveness, taking less than 20 seconds to perform. The scale ranges from -5 (deep sedation) to +4 (extreme agitation), with positive scores indicating agitation (higher score is more agitation so worse outcome) relevant for diagnosing PIA. Screening for PIA will be conducted after the first six ECT treatments by a nurse or medical student who will monitor the patient for 30 minutes in the recovery room. PIA is defined as agitation leading to a score of +1 or greater on the RASS during this period. Patients scoring less than +1 will be recorded as having no PIA for that session. Nurses and medical students will receive training on using the RASS scale, documented in the training log and side delegation file.

Trial sites (2)

FacilityCityRegionStatus
Erasmus Medical Center Rotterdam Netherlands Recruiting
Antes Parnassia Group Rotterdam Netherlands Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06817330 on ClinicalTrials.gov ↗ ← All trials in the Netherlands